Insider Transactions in Q2 2025 at Gemini Therapeutics, Inc. (GMTX)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 16
2025
|
Jean M. Franchi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,000
-2.88%
|
$104,000
$52.26 P/Share
|
|
Jun 06
2025
|
William Jacob Savage Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,996
-5.02%
|
$149,800
$50.0 P/Share
|
|
May 20
2025
|
William Jacob Savage Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,677
-10.06%
|
$333,850
$50.04 P/Share
|
|
May 02
2025
|
William Jacob Savage Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,100
-3.07%
|
$105,000
$50.17 P/Share
|
|
Apr 07
2025
|
John D Quisel Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+4.15%
|
$7,000
$1.01 P/Share
|